Health Care: Drugs

Meridian Bioscience Inc (VIVO: NASDAQ)

$18 n/a | n/a%
12/08/16 - 04:00 PM ET
Company Income Statement
Sep 2016 Sep 2015 Sep 2014 Sep 2013
Sales 196.08M 194.83M 188.83M 188.69M
Cost of Sales 60.58M 66.34M 64.33M 60.49M
Gross Operating Profit 135.50M 128.49M 124.51M 128.20M
Selling, General, and Administrative Expenses 61.11M 53.22M 52.30M 52.94M
Research & Development 13.81M 12.61M 12.55M 10.79M
Operating Income before D & A (EBITDA) 60.58M 62.67M 59.66M 64.47M
Depreciation & Amortization 7.72M 6.61M 7.26M 7.15M
Interest Income 67.00K 23.00K 25.00K 44.00K
Other Income - Net -1.39M -1.02M -309.00K 4.00K
Special Income / Charges 1.48M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 51.54M 55.06M 52.11M 57.36M
Interest Expense 897.00K 0.00 0.00 0.00
Pre-Tax Income 50.64M 55.06M 52.11M 57.36M
Income Taxes 18.41M 19.52M 17.36M 19.33M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 32.23M 35.54M 34.74M 38.03M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 32.23M 35.54M 34.74M 38.03M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 32.23M 35.54M 34.74M 38.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
32.23M 35.54M 34.74M 38.03M
Preferred Dividends
Net Income Available To Common 32.23M 35.54M 34.74M 38.03M
Basic EPS from Continuing Ops. 0.77 0.85 0.84 0.92
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.77 0.85 0.84 0.92
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.77 0.85 0.84 0.92
Basic Normalized Net Income/Share 0.77 0.85 0.84 0.92
EPS fr Continuing Ops. 0.76 0.85 0.83 0.91
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.76 0.85 0.83 0.91
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.76 0.85 0.83 0.91
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.76 0.85 0.83 0.91
Dividends Paid per Share 0.80 0.80 0.79 0.76

Portfolios with VIVO

Latest VIVO Headlines from TheStreet

More Financial News for VIVO

Press Releases for VIVO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter